141 related articles for article (PubMed ID: 22431223)
1. Isolation and characterization of cancer stem cells from cervical cancer HeLa cells.
Zhang SL; Wang YS; Zhou T; Yu XW; Wei ZT; Li YL
Cytotechnology; 2012 Aug; 64(4):477-84. PubMed ID: 22431223
[TBL] [Abstract][Full Text] [Related]
2. [Study of the invasiveness and tumour formation of Bcrp1(+) HeLa cervical cancer cells].
Zhang SL; Yu XW; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):526-9. PubMed ID: 23141165
[TBL] [Abstract][Full Text] [Related]
3. [Research of the characterization of Bcrp1(+) HeLa cells].
Zhang SL; Yu XW; Wei ZT; Fu Y
Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):525-9. PubMed ID: 21029606
[TBL] [Abstract][Full Text] [Related]
4. Side population cells and Bcrp1 expression in lung.
Summer R; Kotton DN; Sun X; Ma B; Fitzsimmons K; Fine A
Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L97-104. PubMed ID: 12626330
[TBL] [Abstract][Full Text] [Related]
5. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo.
Zhou S; Morris JJ; Barnes Y; Lan L; Schuetz JD; Sorrentino BP
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12339-44. PubMed ID: 12218177
[TBL] [Abstract][Full Text] [Related]
6. The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study.
Zhou L; Naraharisetti SB; Wang H; Unadkat JD; Hebert MF; Mao Q
Mol Pharmacol; 2008 Mar; 73(3):949-59. PubMed ID: 18079276
[TBL] [Abstract][Full Text] [Related]
7. A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.
Allen JD; Jackson SC; Schinkel AH
Cancer Res; 2002 Apr; 62(8):2294-9. PubMed ID: 11956086
[TBL] [Abstract][Full Text] [Related]
8. Characterization and localization of side population cells in mouse skin.
Yano S; Ito Y; Fujimoto M; Hamazaki TS; Tamaki K; Okochi H
Stem Cells; 2005; 23(6):834-41. PubMed ID: 15917479
[TBL] [Abstract][Full Text] [Related]
9. Impaired renal excretion of 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole (E3040) sulfate in breast cancer resistance protein (BCRP1/ABCG2) knockout mice.
Mizuno N; Suzuki M; Kusuhara H; Suzuki H; Takeuchi K; Niwa T; Jonker JW; Sugiyama Y
Drug Metab Dispos; 2004 Sep; 32(9):898-901. PubMed ID: 15319327
[TBL] [Abstract][Full Text] [Related]
10. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein.
Allen JD; Van Dort SC; Buitelaar M; van Tellingen O; Schinkel AH
Cancer Res; 2003 Mar; 63(6):1339-44. PubMed ID: 12649196
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan.
de Vries NA; Zhao J; Kroon E; Buckle T; Beijnen JH; van Tellingen O
Clin Cancer Res; 2007 Nov; 13(21):6440-9. PubMed ID: 17975156
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer resistance protein (Bcrp1/Abcg2) reduces systemic exposure of the dietary carcinogens aflatoxin B1, IQ and Trp-P-1 but also mediates their secretion into breast milk.
van Herwaarden AE; Wagenaar E; Karnekamp B; Merino G; Jonker JW; Schinkel AH
Carcinogenesis; 2006 Jan; 27(1):123-30. PubMed ID: 16000399
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of human colorectal cancer stem cells.
Dalerba P; Dylla SJ; Park IK; Liu R; Wang X; Cho RW; Hoey T; Gurney A; Huang EH; Simeone DM; Shelton AA; Parmiani G; Castelli C; Clarke MF
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10158-63. PubMed ID: 17548814
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer-resistance protein (BCRP1) in the fetal mouse brain: development and glucocorticoid regulation.
Petropoulos S; Gibb W; Matthews SG
Biol Reprod; 2011 Apr; 84(4):783-9. PubMed ID: 21159928
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the role of breast cancer resistance protein (Bcrp/Abcg2) on pharmacokinetics and central nervous system penetration of abacavir and zidovudine in the mouse.
Giri N; Shaik N; Pan G; Terasaki T; Mukai C; Kitagaki S; Miyakoshi N; Elmquist WF
Drug Metab Dispos; 2008 Aug; 36(8):1476-84. PubMed ID: 18443033
[TBL] [Abstract][Full Text] [Related]
16. CD71
Leung TH; Tang HW; Siu MK; Chan DW; Chan KK; Cheung AN; Ngan HY
Mol Cancer Res; 2019 Sep; 17(9):1867-1880. PubMed ID: 31235657
[TBL] [Abstract][Full Text] [Related]
17. Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP.
de Vries NA; Buckle T; Zhao J; Beijnen JH; Schellens JH; van Tellingen O
Invest New Drugs; 2012 Apr; 30(2):443-9. PubMed ID: 20963470
[TBL] [Abstract][Full Text] [Related]
18. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
van Herwaarden AE; Jonker JW; Wagenaar E; Brinkhuis RF; Schellens JH; Beijnen JH; Schinkel AH
Cancer Res; 2003 Oct; 63(19):6447-52. PubMed ID: 14559835
[TBL] [Abstract][Full Text] [Related]
19. Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid.
Shen J; Carcaboso AM; Hubbard KE; Tagen M; Wynn HG; Panetta JC; Waters CM; Elmeliegy MA; Stewart CF
Cancer Res; 2009 Jul; 69(14):5885-92. PubMed ID: 19567673
[TBL] [Abstract][Full Text] [Related]
20. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
